search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


GLOBAL RENAL MASS STUDY A PROSPECTIVE INTERNATIONAL STUDY ON INDICATIONS, TREATMENT MODALITIES AND OUTCOMES.


- candidate number6730
- NTR NumberNTR2115
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR18-nov-2009
- Secondary IDs022010 CROES
- Public TitleGLOBAL RENAL MASS STUDY A PROSPECTIVE INTERNATIONAL STUDY ON INDICATIONS, TREATMENT MODALITIES AND OUTCOMES.
- Scientific TitleGLOBAL RENAL MASS STUDY A PROSPECTIVE INTERNATIONAL STUDY ON INDICATIONS, TREATMENT MODALITIES AND OUTCOMES.
- ACRONYMCROES RENAL MASS STUDY
- hypothesisTo assess the current patterns of surgical or instrumental treatment and indications for RCC treatment.
- Healt Condition(s) or Problem(s) studiedRenal mass, Surgical treatment
- Inclusion criteriaEach centre participating in this project will include during a one-year period all the patients treated at their site, with a diagnosis of a renal tumour or candidates for active surveillance (AS).
- Exclusion criteriaNone.
- mec approval receivedno
- multicenter trialyes
- randomisedno
- groupParallel
- TypeSingle arm
- Studytypeobservational
- planned startdate 1-jan-2010
- planned closingdate31-dec-2011
- Target number of participants5000
- InterventionsN/A
- Primary outcomeTo assess the current patterns of surgical or instrumental treatment and indications for RCC treatment.
- Secondary outcome1. To assess perioperative morbidity (30 days) by using the Clavien score;
2. To assess operative complications;
3. To define risk factors for the development of operative and peri-operative morbidity after instrumental treatment;
4. To asses the long term risk of renal insufficiency;
5. To asses pathological characteristics of the renal masses.
- TimepointsOne year inclusion of all data. Data will be collected prospectively. Variables will include preoperative assessment, operative data, histological results and postoperative period until 30 days.
- Trial web sitewww.croesoffice.org
- statusplanned
- CONTACT FOR PUBLIC QUERIES Sonja Rees Vellinga, van
- CONTACT for SCIENTIFIC QUERIES Sonja Rees Vellinga, van
- Sponsor/Initiator Clinical Research Office of the Endourological Society (CROES)
- Funding
(Source(s) of Monetary or Material Support)
Storz
- PublicationsN/A
- Brief summaryOver the last 10 years, we have witnessed an increasing interest in the management of Renal masses. Three main reasons are responsible for this: the increasing diagnostic incidence which leads to the incidental discovery of small renal masses, the development and consolidation of partial nephrectomy and minimal invasive surgical treatments, the latter including both a laparoscopic approach and ablation techniques, and the increasing trend to nephron sparing surgery.
However, there are some fundamental differences concerning the indications for surgery and the technique used, mainly based on experience and institutional characteristics. Those factors may modulate outcomes. Similarly, specific patient and technical factors may influence treatment related morbidity.

In this prospective study we aim to assess on a global basis the indications for treatment and modality and outcomes of surgical treatment for renal masses including (laparoscopic/robotic) radical or partial nephrectomy and (percutaneous/laparoscopic assisted) ablative treatments. Each centre participating in this project will include during a one-year period all the patients treated at their site, with a diagnosis of a renal tumour or candidates for active surveillance (AS).
- Main changes (audit trail)
- RECORD18-nov-2009 - 12-mrt-2010


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl